PrimePath Pro 12 review

Yes, for the right buyer. It is a good annuity for someone who genuinely intends to defer income for ten-plus years, values a built-in rider over an optional one, and wants the chronic-illness backstop built into a single contract. It is a poor fit for anyone who might need flexible access to principal in the early years, who lives in one of the many states where the product is not approved, or who is shopping primarily on guaranteed roll-up strength.

The rational reason to buy PrimePath Pro 12 is to lock in a vehicle that will turn long-term dollars into guaranteed lifetime income later. The built-in rider removes the usual decision of whether to bolt on a GLWB and pay 0.95% to 1.25% for it. The participating roll-up gives the benefit base a chance to grow faster than a flat 6% or 7% rate would in strong index years. And the LPA Multiplier adds a layer of protection most income annuities do not include.

I think this product is best for buyers between roughly age 55 and 65 who are using qualified or non-qualified long-term dollars to backstop a future retirement income plan. The 12-year clock fits cleanly inside a "defer to 70 or later" strategy. It is less attractive for younger buyers who may shift jobs or financial plans, for retirees who are already drawing income, and for anyone who wants short-term liquidity. It is also off the table in roughly two dozen states, so geography matters.

You are not buying index growth. You are buying a long-dated lifetime income contract with a built-in rider and a participating roll-up engine. Two values move side by side inside the contract. Your accumulation value grows or sits flat based on the index strategies you pick. Your benefit base grows by 1.00% plus 200% of the weighted-average interest credit percentage you actually earn each year, for the first fifteen years. When you turn income on, the rider pays a lifetime withdrawal percentage based on the benefit base and your age at activation, regardless of what the accumulation value has done.

The headline feature is the built-in Benefits Rider IV with a participating roll-up. Here is the mechanic. Each contract year for the first fifteen years, the rider credits the benefit base with the greater of two amounts. There is a guaranteed compound roll-up of 1.00%. On top of that, the rider adds 200% of the weighted-average interest credit percentage earned on your strategy allocations that year. So if your strategies credit an average 5% across your allocations, the benefit base grows by roughly 10% that year. If your strategies credit nothing in a flat year, the benefit base still grows by 1.00%.

That is meaningfully different from PrimePath Pro 10's flat 1% roll-up. The Pro 12 design rewards buyers who pick competitive strategies and ride a good index environment. It penalizes buyers who sit in conservative allocations in flat markets, because the guaranteed floor is small. Two buyers with the same premium and same activation age can end up with very different lifetime payments.

There are also two benefit-base bonuses. If you take no withdrawals before the end of year five, the rider adds 5% of initial premium to the benefit base. If you also take no withdrawals or Lifetime Payment Amounts before the end of year ten, it adds another 5%. These bonuses live on the benefit base only, not the accumulation value, so they cannot be surrendered for cash.

The LPA Multiplier is the secondary feature worth understanding. If you cannot perform two of six activities of daily living, the rider can double your Lifetime Payment Amount for a defined period. That kind of chronic-illness doubler is not standard on income FIAs and effectively bakes a partial long-term-care benefit into the contract at no separate fee. It can be the difference between an income stream that covers ordinary retirement expenses and one that meaningfully helps with care costs at the moment when care costs hit.

The crediting menu is broad. You have access to S&P 500, several S&P risk-controlled indices, and two Morgan Stanley dynamic indices, with annual, monthly, and two-year point-to-point options that can use caps, margins, participation rates, or enhanced participation rates. The Enhanced Participation Rate strategies carry a 0.95% annual strategy charge, which is the only crediting-side fee in the contract. Current rates effective in early 2024 included caps ranging from 2.30% to 7.75%, participation rates from 30% to 175%, and a 3.20% fixed account, but rate sheets change and your agent should pull the current numbers.

PrimePath Pro 12 is a long-term commitment with steep early exit costs. The surrender schedule starts at 14% in years one and two, stays in double digits through year seven, and does not fully drop off until year thirteen. A market value adjustment also applies on amounts above the free-withdrawal allowance, which can either soften or amplify the charge depending on interest-rate moves at the time of withdrawal.

You can take up to 7% of the beginning-of-year accumulation value penalty-free each year after year one. A nursing-home confinement waiver allows full surrender without charge or MVA if you are confined to a qualifying facility for ninety or more consecutive days, though that waiver is not available in every state. In California, the MVA is capped at the lesser of the surrender charge or 0.50% of accumulation value, which is meaningfully more buyer-friendly than the standard MVA in other states.

The practical takeaway is straightforward. Treat this contract as locked dollars for twelve years. The 7% annual free withdrawal is enough to support some income needs, but anything beyond it during the surrender period is expensive.

The fee structure on PrimePath Pro 12 is unusually clean for a built-in income product. There is no separate rider fee. The base contract has no explicit annual product fee. The only crediting-side cost is the 0.95% strategy charge that applies if you allocate to one of the Enhanced Participation Rate strategies, and that charge can be avoided by choosing a different crediting method.

The tradeoffs are structural rather than fee-based. The participating roll-up is genuinely participating, which means flat index years produce only the 1.00% guaranteed minimum. The benefit-base bonuses require strict no-withdrawal discipline through the five- and ten-year marks. And the long surrender schedule means the contract is illiquid in any practical sense during the first decade. None of that is hidden, but it is the real cost.